BRIEF published on 06/18/2025 at 07:05, 1 year 5 months ago PHAXIAM Therapeutics suspends trading of its shares Euronext Paris Innovative Treatments PHAXIAM Suspension Of Quotation Delisting Securities
BRIEF published on 06/18/2025 at 07:05, 1 year 5 months ago PHAXIAM Therapeutics suspend la cotation de son titre Euronext Paris Suspension Cotation Traitements Innovants PHAXIAM Radiation Titres
PRESS RELEASE published on 06/18/2025 at 07:00, 1 year 5 months ago Inside Information / Other news releases PHAXIAM Therapeutics suspends trading shares for delisting on Euronext Paris market. No reimbursement to shareholders. Company focuses on innovative phage-based treatments for resistant bacterial infections Trading Delisting Suspension PHAXIAM Therapeutics Phage-based Treatments
PRESS RELEASE published on 06/18/2025 at 07:00, 1 year 5 months ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics suspend la cotation de son titre sur Euronext Paris en raison d'un prochain retrait de la cote, sans remboursement aux actionnaires Euronext Paris Cotation Suspension Retrait PHAXIAM Therapeutics
BRIEF published on 06/05/2025 at 07:05, 1 year 5 months ago PHAXIAM Therapeutics Facing Potential Liquidation Amid Court Hearing Postponement Biopharmaceuticals Judicial Liquidation Court Hearing PHAXIAM Therapeutics Euronext Delisting
BRIEF published on 06/05/2025 at 07:05, 1 year 5 months ago PHAXIAM Therapeutics menacée de liquidation suite au report de l'audience Liquidation Judiciaire Produits Biopharmaceutiques PHAXIAM Thérapeutique Audience Au Tribunal Radiation D'Euronext
PRESS RELEASE published on 06/05/2025 at 07:00, 1 year 5 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces new postponement of Offer Review Hearing by Lyon Commercial Court to June 11, 2025. Company to request delisting from Euronext Euronext Delisting Postponement PHAXIAM Therapeutics Lyon Commercial Court
BRIEF published on 03/14/2025 at 17:50, 1 year 8 months ago PHAXIAM Therapeutics cherche repreneur en redressement judiciaire Euronext Paris Redressement Judiciaire PHAXIAM Therapeutics Recherche Repreneur Prolongation Procédure
BRIEF published on 03/14/2025 at 17:50, 1 year 8 months ago PHAXIAM Therapeutics seeks buyer in receivership Euronext Paris PHAXIAM Therapeutics Judicial Recovery Looking For A Buyer Extension Of Procedure
PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 8 months ago Inside Information / Other news releases PHAXIAM Therapeutics launches bidding process to find buyers amid receivership, trading of shares to resume on Euronext Paris. Court decides on procedure extension on April 30, 2025 Euronext Paris Receivership PHAXIAM Therapeutics Court Decision Bidding Process
Published on 11/20/2026 at 15:00, 22 hours 1 minute ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 22 hours 11 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 23 hours 1 minute ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 23 hours 31 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 23 hours 31 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 13 hours 15 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 14 hours 21 minutes ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 15 hours 24 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 16 hours 11 minutes ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 18 hours 26 minutes ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 18 hours 26 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 19 hours 26 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 19 hours 26 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 18 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR